BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06726265-completion@plaintrial.com
DTSTAMP:20261028T174936Z
DTSTART;VALUE=DATE:202909
SUMMARY:Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab 
 and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chem
 otherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC
 ) (TACTI-004) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT06726265
URL:https://plaintrial.com/trial/NCT06726265
END:VEVENT
END:VCALENDAR